Vifor Pharma - Company & Market Research Reports

Vifor Pharma Group is a global specialty pharmaceuticals company. The company’s goal is to be a global leader in iron deficiency, nephrology and cardio-renal therapies. Its product portfolio includes intravenous products, Ferinject and Venofer, and an oral product, Maltofer. The company was founded at the end of 2010 and is owned 55% by Vifor Pharma Group (formerly Galenica Group) and 45% by Fresenius Medical Care. Vifor Pharma’s operational headquarters are in Zurich, Switzerland.

Intravenous (IV) Iron Drugs - Global Strategic Business Report - Product Thumbnail Image

Intravenous (IV) Iron Drugs - Global Strategic Business Report

  • Report
  • 165 Pages
From
Global Intravenous (IV) Iron and Oral Iron Market - Strategic Assessment and Forecast Till 2021 - Product Thumbnail Image

Global Intravenous (IV) Iron and Oral Iron Market - Strategic Assessment and Forecast Till 2021

  • Report
  • 94 Pages
From
Thalassemia Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments - Product Thumbnail Image

Thalassemia Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

  • Report
  • 98 Pages
From
Hemochromatosis Pipeline Analysis 2018 (Q1) - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments - Product Thumbnail Image

Hemochromatosis Pipeline Analysis 2018 (Q1) - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

  • Report
  • 85 Pages
From
2018 Chronic Heart Failure Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Chronic Heart Failure Market - Product Thumbnail Image

2018 Chronic Heart Failure Drug Development Pipeline Analysis Report- Companies, Drugs, Clinical Trials, Latest Developments in Chronic Heart Failure Market

  • Report
  • 70 Pages
From
Biologics Outsourcing Global Market - Forecast to 2025 - Product Thumbnail Image

Biologics Outsourcing Global Market - Forecast to 2025

  • Report
  • 527 Pages
From
Drug Overview: Feraheme - Product Thumbnail Image

Drug Overview: Feraheme

  • Drug Pipelines
  • 8 Pages
From
Focal Segmental Glomerulosclerosis (FSGS) Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments - Product Thumbnail Image

Focal Segmental Glomerulosclerosis (FSGS) Pipeline Analysis 2018 - Focusing on Clinical Trials and Results, Drug Profiling, Patents, Collaborations, and Other Recent Developments

  • Report
  • 85 Pages
From
Global Iron Drugs Market 2018-2022 - Product Thumbnail Image

Global Iron Drugs Market 2018-2022

  • Report
  • 98 Pages
From
Hemochromatosis - Pipeline Review, H1 2018 - Product Thumbnail Image

Hemochromatosis - Pipeline Review, H1 2018

  • Report
  • 41 Pages
From
Thalassemia - Pipeline Review, H1 2018 - Product Thumbnail Image

Thalassemia - Pipeline Review, H1 2018

  • Report
  • 148 Pages
From
Global Intravenous (IV) Therapy and Vein Access Market Analysis & Trends - Industry Forecast to 2025 - Product Thumbnail Image

Global Intravenous (IV) Therapy and Vein Access Market Analysis & Trends - Industry Forecast to 2025

  • Report
  • 159 Pages
From
Global Market for Erythropoietin: 2015-2020 - Product Thumbnail Image

Global Market for Erythropoietin: 2015-2020

  • Report
  • 110 Pages
From
Global Intravenous (IV) Solutions Market Analysis 2016 - Forecast to 2022 - Product Thumbnail Image

Global Intravenous (IV) Solutions Market Analysis 2016 - Forecast to 2022

  • Report
  • 171 Pages
From
Intravenous - Global Opportunity Analysis and Industry Forecast, 2017-2023 - Product Thumbnail Image

Intravenous - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • Report
  • 175 Pages
From
Global Intravenous Solutions Market 2016-2020 - Product Thumbnail Image

Global Intravenous Solutions Market 2016-2020

  • Report
  • 53 Pages
From
PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2018 Edition - Product Thumbnail Image

PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2018 Edition

  • Report
  • 43 Pages
From
Keryx's Zerenex - Novel phosphate binder for use in the dialysis setting - Product Thumbnail Image

Keryx's Zerenex - Novel phosphate binder for use in the dialysis setting

  • Report
  • 35 Pages
From
Life Cycle Management Strategies - Optimizing Revenues and Defending Generic Competition - Product Thumbnail Image

Life Cycle Management Strategies - Optimizing Revenues and Defending Generic Competition

  • Report
  • 100 Pages
From
Hyperkalemia Global Clinical Trials Review, H2, 2017 - Product Thumbnail Image

Hyperkalemia Global Clinical Trials Review, H2, 2017

  • Clinical Trials
  • 59 Pages
From
Loading Indicator
adroll